EUR · 1 valued
€133,274
Supplier · public contract awards
Institut für molekulare Biotechnologie GmbH (IMBA) public contracts.
Institut für molekulare Biotechnologie GmbH (IMBA) has won 2 public contracts in 2024 from 1 public buyer in Austria. Its most frequent buyer is Vienna BioCenter Core Facilities GmbH (2 awards). Outside TED, published values total €133,274 across 1 award.
2Contracts won
1Public buyers
1Country
Aug 2024Latest award
Latest contracts won
Kooperationsvertrag zum gemeinsamen Betrieb von Forschungsinfrastrukturen - VBCF
Awarded by Vienna BioCenter Core Facilities GmbH · Austria
19 Aug 2024Awarded
Contracts won by year
Published value, by currency (feeds other than TED)
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against Institut für molekulare Biotechnologie GmbH (IMBA)?
askTender reads any open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
askTender See open tenders